HIV/AIDS News

People with virally suppressed HIV who are hospitalized with community acquired pneumonia do not have a higher mortality risk than people without HIV, according to a study.

A new study provides the first evidence that illicit fentanyl use may play a role in hepatitis C transmission among injection drug users, according to researchers.

CMS included a new infectious disease consult add-on code as part of its proposed new fee schedule could help improve compensation for ID clinicians, according to the Infectious Diseases Society of America.

Two experimental HIV vaccine regimens failed to reduce infections in a 3-year trial in eastern and southern Africa compared with participants who were taking a placebo, some of whom were on oral PrEP, according to a study.

ID is a dynamic field that is constantly changing. The types of infections we’re talking about today are different than what we may have been talking about 5 years ago. So, it’s intellectually stimulating and challenging.

Testing HIV PrEP users for STIs every 6 months did not increase the risk for STIs compared with testing them every 3 months and could reduce the cost of PrEP programs, according to a study.

Three-quarters of people globally living with HIV are on ART, a roughly 30% increase during the last nine years, and fewer people acquired HIV in 2023 than at any point since the late 1980s, UNAIDS reported.

A self-management program tailored to individuals with HIV significantly reduced the impact and severity of chronic pain, according to results from a randomized study published in JAMA Internal Medicine.

In June, Gilead Sciences announced that its investigational antiretroviral drug lenacapavir prevented 100% of new HIV infections during a phase 3 trial conducted among cisgender women in Africa.

Despite global progress toward eliminating HIV — including a growing number of nations that have hit goals to diagnose and successfully treat patients — funding pullbacks threaten to add decades to the battle, according to a study.